Text Size
Trial record 6 of 42 for:    endocarditis
Previous Study | Return to List | Next Study

Cardiac Computed Tomography (CT) Scan Compared to Transesophageal Echocardiogram (TEE) in Endocarditis

This study has been terminated.
(Difficult recruitment)
Sponsor:
Information provided by (Responsible Party):
Lihua QU, William Beaumont Hospitals
ClinicalTrials.gov Identifier:
NCT00995384
First received: October 14, 2009
Last updated: March 21, 2012
Last verified: March 2012
History of Changes
  Purpose

The purpose of this study is to assess the effectiveness of cardiac CT versus TEE in endocarditis patients.


Condition Intervention
Endocarditis
 Procedure: CT Scan

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Diagnostic
Official Title: A Novel Modality of Cardiac CT in Characterization of Acute Infective Endocarditis

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by William Beaumont Hospitals:

Primary Outcome Measures:
  • Visual Difference in CT versus TEE images in Endocarditis [ Time Frame: Upon CT Scan ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Morbidity [ Time Frame: 4 weeks & 6 months post CT scan ] [ Designated as safety issue: No ]

Enrollment: 2
Study Start Date: October 2009
Study Completion Date: October 2010
Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
CT scan
CT Scan for endocarditis patients. All patients receive intervention.
 Procedure: CT Scan
Cardiac CT with special attention to valves in Endocarditis patients.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Acute endocarditis with positive TEE

Exclusion Criteria:

  • Renal failure
  • Contrast dye allergy
  • Beta-blocker allergy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00995384

Locations
United States, Michigan
William Beaumont Hosptial
Royal Oak, Michigan, United States, 48073
Sponsors and Collaborators
William Beaumont Hospitals
Investigators
Principal Investigator: Phillip Kadaj, MD William Beaumont Hospitals
  More Information

No publications provided

Responsible Party: Lihua QU, Coordinator, William Beaumont Hospitals
ClinicalTrials.gov Identifier: NCT00995384     History of Changes
Other Study ID Numbers: HIC 2009-148, R/C# 98699, RI-09-17
Study First Received: October 14, 2009
Last Updated: March 21, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Endocarditis
Heart Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on May 23, 2013